FDA Chief Scott Gottlieb abruptly resigns
Gottlieb’s FDA has earned its fair share of criticism. Gottlieb also took fire for his agency’s decision to approve Dsuvia, the tablet form of an opioid painkiller more potent than fentanyl. He was also criticized for pushing back the timetable for when new regulatory rules would apply to e-cigarette products, similar to how tobacco cigarettes are regulated.…
Recent Comments